Stockreport

Simulations Plus Supported Development of Every FDA-Approved Drug in 2024

Simulations Plus, Inc.  (SLP) 
Last simulations plus, inc. earnings: 4/9 04:35 pm Check Earnings Report
US:NASDAQ Investor Relations: simulations-plus.com/software/overview
PDF SLP’s technology and expertise accelerates drug development and supports critical advancements in global healthcare RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Sim [Read more]